Company ProfilePremium

Stockhausen Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Stockhausen Inc. - Company showcase

Year Founded & Workforce

1873

1,000 Employees

Stockhausen Inc. logo

Stockhausen Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Stockhausen Inc. Overview

Stockhausen is one of the oldest names in Western superabsorbent polymer manufacturing. It is a backward-integrated producer of SAP and its key feedstock, acrylic acid. Its Krefeld site ran the world's first large-scale SAP plant in 1986, and its FAVOR® brand was in more than 40 billion diapers a year by 2011.

After almost two decades inside Degussa and Evonik, the business returned to independence under private-equity-style ownership. ICIG bought it in August 2024 as a standalone "Superabsorber platform" and revived the heritage name. Stockhausen sells only to other businesses. Its customers are global hygiene converters (baby diapers, feminine care, adult incontinence) and niche technical markets: cable water-blocking, swellable elastomers, agricultural water retention and food-packaging pads.

The business has strong application-technology know-how, but it competes in a commoditising, Asia-weighted market. By Evonik's account, it earned thin margins, averaging around €20 million of adjusted EBITDA a year over 2019–2023 on sales of about €0.9 billion. Its investment case rests on a carve-out turnaround, bio-based products and cost discipline.


Company's own description

On its website, Stockhausen calls itself a global manufacturer of superabsorbers that has been "keeping things dry" for more than 40 years. It says its products serve people across the life course: baby diapers, menstrual care and incontinence products, plus agricultural and industrial uses where moisture control matters. Acrylic acid is described as the core of its technology. The company makes acrylic acid for its own SAP and sells some to outside customers. It states that it has belonged to ICIG since 2024 and that it sells B2B only [Source: stockhausen.com About Us and Products, accessed Oct 2026].

ICIG presents Stockhausen as its superabsorber platform, formed in 2024. In ICIG's description, the platform has five manufacturing sites in Europe and the US (an acrylic acid plant in Marl plus SAP plants in Krefeld, Rheinmünster, Greensboro and Garyville) and two R&D and innovation centres in Greensboro and Krefeld. ICIG calls it a full-service supplier to the SAP industry and a leader in application technology [Source: ic-investors.com Stockhausen platform page].

Independent characterisation

Stockhausen is an integrated, mid-tier commodity-to-semi-specialty polymer producer. Its economics depend on three spreads:

Propylene to acrylic acid: at Marl.

Acrylic acid to SAP: across the four SAP plants.

  • SAP list prices, which are set through contracts with a concentrated customer base of global diaper makers and private-label converters.

The hygiene grades, mainly FAVOR®, almost certainly make up the large majority of volume and revenue. The technical grades (CABLOC®, CREABLOC®, STOCKOSORB®, FAVOR® Pac) carry higher unit value but are small in tonnage. No product-level split is disclosed.

Business model and revenue model

Revenue typeDescriptionEstimated weightBasis
Product sales: hygiene SAP (FAVOR®)Tonnage contracts with diaper, feminine-care and incontinence manufacturersDominant (exact share not disclosed)stockhausen.com; Evonik described the unit as "superabsorbents for diapers and hygiene"
Product sales: technical SAPCABLOC® (cable), CREABLOC® (elastomer seals, downhole packers), STOCKOSORB® (horticulture/agriculture), FAVOR® Pac (food pads)Minor (not disclosed)stockhausen.com Products
Product sales: merchant acrylic acidSurplus acrylic acid from Marl sold to paints, coatings and flocculant producersMinor (not disclosed)stockhausen.com Products
ServicesApplication technology and co-development with customers, bundled into product pricing rather than billed separatelyNot separately monetisedstockhausen.com; Evonik 2015 application-centre release
Licensing / subscriptionNone disclosed——

Value-chain position

The company buys propylene, a petrochemical feedstock, and supplies the Marl acrylic acid plant from it. Marl sits in Chemiepark Marl, a large integrated chemical park. The SAP plants then polymerise and crosslink acrylic acid with caustic soda into SAP granulate. Customers are converters: branded diaper makers and private-label producers. Stockhausen does not sell to consumers.

Customer types and end-markets

End-marketProductsCustomer type
Baby care (diapers)FAVOR®Global and regional diaper OEMs, private-label converters
Feminine careFAVOR®Hygiene converters
Adult incontinenceFAVOR® (including odour-control grades)Hygiene converters, medical-supply brands
Food packagingFAVOR® Pac (FDA-cleared and EU food-contact compliant)Absorbent pad makers, meat and poultry packers
Wire and cableCABLOC®Power and telecom cable makers
Civil engineering, oil and gas, geothermal, miningCREABLOC®Rubber compounders, makers of swellable seals and packers
Horticulture and agricultureSTOCKOSORB®Nurseries, greenhouses, roof-greening and vertical-farming operators
Coatings, paints, flocculantsAcrylic acidChemical producers

Strategy

Stated strategic themes

Stockhausen publishes no annual report or investor-day materials. From its website and owner communications, the main themes are:

  1. Heritage and customer intimacy. The Stockhausen name was revived to combine long experience with a clear focus on the future. Co-development and tailored FAVOR® grades are central to the pitch.

  2. Backward integration into acrylic acid. Marl is presented as a differentiator for quality and security of supply.

  3. Sustainability-led differentiation. Priorities are FAVOR® Bio (cellulose-based, biodegradable SAP), ISCC PLUS mass-balance products with up to 100% allocation, lower CO₂ footprint, less waste, and efficient use of raw materials.

  4. Application-technology leadership. ICIG describes Stockhausen as a market leader in application technology with a global team of technical experts.

  5. Standalone growth platform. ICIG said at signing that the business, as a new platform, would offer the group new growth opportunities.

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDescriptionTargets disclosed?Source
Carve-out and rebrandSep–Oct 2024Separated from Evonik IT, HR and legal; Stockhausen Superabsorber GmbH registeredNostockhausen.com News
FAVOR® Bio commercialisation2025–2026Bio-based SAP offered to selected partners; commercial scale signalled as comingNo volume or timing targetsstockhausen.com Products / Sustainability
ISCC PLUS mass balanceOngoingSAP and acrylic acid in Germany certifiedNostockhausen.com Sustainability
Efficiency programmesOngoingCompany reports completing significant projects to cut raw-material input factors, waste and by-productsNo quantified targetsstockhausen.com Sustainability
EcoVadis Silver2,025Third-party ESG rating; top 15% of assessed companies—stockhausen.com
Fairness & Inclusion policy2025–2026Published diversity, fairness and inclusion statementNo metricsstockhausen.com News
Possible North American footprint rationalisation2025–2026 (unconfirmed)Garyville not on the company's site list; WARN aggregator entry—stockhausen.com Sites; warnfirehose.com (low reliability)
CEO transition1 Oct 2026New CEO with transformation background—stockhausen.com News

Medium-term financial targets / guidance

None publicly disclosed.

Products & Services

All product descriptions are taken from stockhausen.com (Products page, accessed Oct 2026) unless noted. Pricing is not publicly disclosed for any product. SAP is typically sold under negotiated annual or quarterly contracts, often indexed to raw-material costs; this is an industry norm and is not disclosed by the company.

FAVOR® (hygiene superabsorber)

AttributeDetail
DescriptionCrosslinked network of hydrophilic polymer chains that absorbs liquid, turns it into gel and holds it even under pressure
Key capabilitiesAbsorbs up to about 500 times its own weight, depending on the liquid; tailored grades; optional odour control for incontinence and hygiene products
Development generations (company account)1986: focus on total capacity. Next generation: retention under pressure. 1996: faster absorption, enabling thinner diapers. 1998: better liquid distribution through higher gel permeability
Target customersMakers of baby diapers, feminine-care and adult-incontinence products
Launch yearProcess developed 1985; large-scale production from 1986
Scale indicatorIn more than 40 billion diapers a year (Evonik, 2011)
Industry context (company-provided)Early diapers held about 50 g of cellulose and 2 g of SAP. By 1999, a typical diaper held 18 g of cellulose and 15 g of SAP, and the ratio is now close to 1:1. Total absorption rose from about 100 g to more than 400 g
Pricing modelNot publicly disclosed (B2B contract)

FAVOR® Bio (bio-based / biodegradable superabsorber)

AttributeDetail
DescriptionBio-based SAP approach aimed at hygiene-grade performance. The sustainability page stresses cellulose-based SAP and biodegradability
StatusThe company describes it as in a focused market phase, discussed directly with selected partners. Commercial-scale supply is signalled as upcoming
Target customersHygiene brands seeking greener product claims
Launch yearNot disclosed (development under Evonik and ICIG; commercial scale pending as of 2026)
Pricing—

FAVOR® Pac (food-packaging SAP)

AttributeDetail
DescriptionSAP for absorbent pads in food packaging (meat, poultry) and leak-protection underlays in transport
Key capabilitiesComplies with European food-packaging legislation or is FDA-approved, depending on grade; high retention under pressure; fast swelling; resists ageing and microorganisms; supports lightweight pads
Regulatory historyStockhausen, Inc. petitioned the FDA in 1997 (petition 2B4323 amendment) to allow a grafted copolymer of crosslinked sodium polyacrylate with polyvinyl alcohol in poultry pads, made in Greensboro
Target customersAbsorbent-pad makers, protein packers
Pricing—

CABLOC® (wire and cable water-blocking)

AttributeDetail
DescriptionCrosslinkable homopolymers with water-binding groups. Insoluble in water when dry but highly swellable; they block water from entering power and telecom cables and seal damaged sections
Application methodsFluidised bed, electrostatic and vibratory application onto tapes, yarns and substrates
Key capabilitiesFast swelling, high gel strength, mechanical stability, anti-corrosive, ageing- and microbe-resistant, non-toxic
Target customersPower and communication cable makers; water-blocking tape and yarn producers
Pricing—

CREABLOC® (swellable elastomer SAP)

AttributeDetail
DescriptionSalt-resistant, long-term-stable SAP for elastomer and thermoplastic compounds, usually blended with EPDM to make them swell in water
ApplicationsSwellable rubber seal profiles and gaskets in civil engineering; swellable downhole packers in oil and gas, geothermal and mining
Target customersRubber compounders, makers of oilfield completion equipment
Pricing—

STOCKOSORB® (agricultural / horticultural water retention)

AttributeDetail
DescriptionSAP mixed into soil or substrate to retain moisture (the company's slogan reverses "keep things dry" to "keep things moist")
ApplicationMixed by hand, dry or pre-hydrated, into pots, containers and bags; nurseries, greenhouses, roof greening, vertical farming
Claimed benefitsHigher seedling survival, better root growth under heat and drought, lower water and fertiliser use, less run-off and erosion, earlier harvest
Target customersCommercial horticulture, landscaping, agriculture, garden centres
Pricing—

Acrylic acid (merchant sales)

AttributeDetail
DescriptionMain raw material for SAP, made at Marl, Germany; surplus sold to third parties
Downstream usesPaints, coatings, flocculants
CertificationsISO 9001, ISO 14001 / EMAS, ISO 50001; ISCC PLUS mass-balance certification in Germany
Capacity—
PricingNot publicly disclosed (typically indexed to market benchmarks)

Services

Application technology and co-development: Customers can work with Stockhausen labs on tailored SAP blends. Under Evonik, the business opened a €1 million application-technology centre in Krefeld in April 2015 [Source: Evonik press release, 27 Apr 2015].

Mass-balance certified supply: Products can be supplied with ISCC PLUS mass-balance allocation of up to 100% [Source: stockhausen.com Sustainability].

Financial Narrative

Disclosure context

Stockhausen is privately held and publishes no consolidated accounts. The only verified standalone figures come from Evonik's divestment disclosure in March 2024:

The German GmbH is required to file annual financial statements in the Unternehmensregister. Analysts needing audited figures should pull HRB 20668 filings directly.

Income statement (chartable format; blank = not publicly disclosed)

EPS and DPS do not apply because the company has a single private shareholder.

Margins (chartable format)

Derived observation, not a reported figure. If "mid double-digit millions" is taken as roughly €40–60 million, the FY2023 adjusted EBITDA margin was about 4.5–6.7% of sales. The five-year average of about €20 million against sales of €0.9–1.0 billion implies an average margin near 2%. These are analytical ranges inferred from Evonik's wording, not disclosed numbers, so they are not entered in the chartable table.

Revenue CAGR

This cannot be calculated: only one year (FY2023) is disclosed.

Balance sheet (chartable format)

Context. Evonik impaired €301 million of Performance Materials goodwill in FY2022 [Source: Evonik FY2022 results]. The allocation between superabsorbents and C4 was not disclosed. A purchase price in the low hundreds of millions for about €0.9 billion of sales (roughly 0.1–0.4x EV/Sales) suggests the acquisition balance sheet was valued well below historical book value. That is an inference, not a disclosure.

Ratios

Not publicly disclosed: ROE, ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle. None can be calculated without balance-sheet data.

Commentary on trends, inflections and drivers

Evonik's disclosures, though limited, describe a business with structurally low profitability and high cyclicality. EBITDA averaged about €20 million a year over five years on sales of around €0.9 billion. That is thin for an asset-heavy, five-plant, backward-integrated operation, and it probably fell short of covering maintenance capex in some years. This is an inference; capex is not disclosed.

2021–2022. Sales were driven largely by price. Acrylic acid and propylene costs rose sharply in the 2021–2022 commodity spike, and SAP producers passed costs through with a lag. Evonik reported that superabsorbent sales rose in 2022 as market conditions improved.

2023. Sales of €892 million fell year on year because European demand weakened. Even so, the business reached EBITDA in the "mid double-digit millions", above its five-year average. The likely explanation is easing raw-material costs that improved the spread even as volumes and prices fell. This is an inference.

2024 carve-out. The low triple-digit-million price confirms that both Evonik and ICIG saw the asset as a turnaround candidate rather than a stable cash generator.

2025–2026 (no disclosed data). Three qualitative signals stand out:

  • The company's reference to strengthening the business in a challenging market environment (CEO transition release, Oct 2026).

  • The apparent drop from five to four listed sites, with the Garyville facility no longer on the company's site list.

  • A Louisiana WARN Act entry for "Stockhausen Superabsorber" in early 2026 on a third-party aggregator. Its worker count is clearly garbled and unreliable.

Taken together, these signals point to capacity restructuring in North America. This is unconfirmed by the company.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionRoleSource

ICI Holding SE / International Chemical Investors Group

Germany (Frankfurt)

Ultimate owner; privately held industrial holding

ic-investors.com

Stockhausen Superabsorber GmbH

Germany (Krefeld, HRB 20668)

Operating parent; runs Krefeld, Rheinmünster and Marl

stockhausen.com

Stockhausen Superabsorber LLC

USA

US operating entity, Greensboro (formerly Stockhausen, Inc.)

stockhausen.com Sites; USPTO

Garyville, LA operation

USA

SAP plant at 3606 LA-44, Garyville; legal entity not confirmed; current status unclear

ic-investors.com Garyville page

Functional Group Details

Functional group (analyst construct)ContentsProducts

Hygiene SAP

Baby, feminine and adult-incontinence SAP

FAVOR®, FAVOR® Bio (development/limited commercial)

Specialty/technical SAP

Industrial and agricultural SAP

FAVOR® Pac, CABLOC®, CREABLOC®, STOCKOSORB®

Acrylic acid (merchant)

Surplus acrylic acid from Marl

Glacial/crude acrylic acid (grades not disclosed)

Revenue by Segment

MetricFY2023

Total business sales (EUR Mn)

892

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (FY2022–FY2023)

MetricFY2022FY2023

Evonik Performance Materials sales (EUR Mn)

3,660—

Evonik Performance Materials adj. EBITDA (EUR Mn)

409111

Data Point Details

Data pointValuePeriodSource

Sales

€892 million

FY2023

Evonik press release, 4 Mar 2024

Adjusted EBITDA

"Mid double-digit million euro range" (no exact figure)

FY2023

Evonik press release, 4 Mar 2024

Adjusted EBITDA, five-year average

About €20 million per year

Roughly FY2019–FY2023

Evonik press release, 4 Mar 2024

Enterprise value / purchase price

"Low triple-digit million euro range"

Signed Mar 2024; closed 31 Aug 2024

Evonik press release

Employees

About 1,000

2023/2024

Evonik closing release

2023 demand commentary

Sales fell in 2023 on weaker European demand

FY2023

Specialty Chemicals Magazine

2022 commentary

Superabsorbent sales rose in 2022, helped by better market conditions

FY2022

PCI Magazine / Evonik FY2022

Income Statement

MetricFY2023

Revenue (EUR Mn)

892

Region Overview

RegionSitesFunctions

Germany

Krefeld, Rheinmünster, Marl

SAP (Krefeld, Rheinmünster); acrylic acid (Marl); R&D and application technology (Krefeld)

United States

Greensboro, NC; Garyville, LA (status uncertain)

SAP; R&D (Greensboro)

Asia, Latin America, Middle East

No disclosed production

Served by export, if at all

Capital Markets

ItemStatus

Share price performance (1/3/5-year)

Not applicable (unlisted)

Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B)

Not applicable. Transaction-implied: the low triple-digit million euro price on €892M FY2023 sales implies EV/Sales of roughly 0.1x–0.4x. Against "mid double-digit million" FY2023 EBITDA, EV/EBITDA would be roughly 2x–7x. These are analytical ranges from Evonik's wording, not disclosed multiples

Analyst consensus

None (no coverage)

Dividend history and policy

Not publicly disclosed (single private shareholder)

Credit ratings (Moody's / S&P / Fitch)

None found; no public rating

Listed peer reference

Nippon Shokubai, BASF, LG Chem, Sumitomo Seika and Formosa Plastics are listed but report SAP inside broader segments; peer SAP multiples cannot be isolated

Capital Markets Data

MetricFY2023

Disclosed sales base for valuation (EUR Mn)

892

Analyst Conclusions

Management guidance

None publicly disclosed. Qualitative signals are a focus on transformation (CEO appointment, Oct 2026), FAVOR® Bio commercialisation and efficiency programmes.

Consensus growth expectations

No company consensus exists. For the market, third-party estimates put SAP growth at about 5.8–6.1% a year through the early 2030s [GMI; Reports and Insights], led by Asia-Pacific.

Bull case

  1. Turnaround from a low base. A business bought for a low triple-digit million price that reached "mid double-digit million" EBITDA in FY2023 has substantial operating leverage if spreads normalise and carve-out costs are cut.

  2. Sustainability premium. FAVOR® Bio and 100%-allocation mass-balance products could earn premium pricing and preferred-supplier status with hygiene brands chasing scope-3 targets.

  3. Footprint optimisation. Exiting under-utilised US capacity (if Garyville is confirmed) and focusing on Greensboro and the German sites could raise utilisation and margins.

Bear case

  1. Structural cost disadvantage. Three German sites carry European energy and CO₂ costs against Asian rivals with newer capacity.

  2. Low historical returns. Average EBITDA of about €20M a year over five years suggests the business may not reliably earn its cost of capital through the cycle.

  3. Demographic and customer pressure. Falling birth rates in home markets and strong buyer power among diaper makers cap volume growth and pricing.

Catalysts and monitorables (next 12 months)

  • The new CEO's first strategic announcements (Q4 2026 to H1 2027).

  • Official confirmation of the Garyville site's status and any related restructuring.

  • A FAVOR® Bio commercial-scale launch announcement.

  • Filing of German statutory accounts for FY2024 and FY2025 (Unternehmensregister).

  • European energy prices and acrylic acid spreads.

  • Any ICIG portfolio action (bolt-on acquisitions or a partial sale).

Analyst verdict

The entity searched as "Stockhausen Inc." is not a public company. It is the US arm of Stockhausen Superabsorber, a heritage German SAP and acrylic acid producer that ICIG bought from Evonik in August 2024 for a price Evonik described as in the low triple-digit million euro range. The business has real assets: integrated acrylic acid at Marl, four or five SAP plants, a pioneering technology history going back to the world's first large-scale SAP plant in 1986, a respected brand (FAVOR®) and credible sustainability credentials. Its economics, however, have been poor. Evonik's own numbers show adjusted EBITDA averaging about €20 million a year on sales near €0.9 billion. That profile explains both why Evonik sold and why the price was so low.

Under ICIG, the playbook is clear: separate, simplify, cut costs, rationalise capacity and differentiate through sustainability. There is some public evidence of progress. The carve-out and rebrand are complete, the company holds an EcoVadis Silver rating and ISCC PLUS certification, and FAVOR® Bio is nearing commercial scale. The company's site list now shows four sites rather than five, which suggests the North American footprint is being restructured, though no announcement confirms this. The CEO change on 1 October 2026, bringing in an executive with transformation experience at INEOS Styrolution, signals that the owner wants faster change.

The main limitation of this assessment is disclosure. No post-carve-out financials are public, so any judgement on the turnaround's success is provisional. For counterparties, Stockhausen is likely to remain a technically capable, reliable supplier, especially in Europe and North America. For anyone assessing it as an investment, it is a carve-out turnaround with credible upside if spreads normalise and bio-SAP scales, set against structural pressure from European costs and Asian competition. Treat it as a watch until audited FY2025 accounts and the new CEO's strategy are available.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior rolesEducation

Dr. Eike Jahnke

CEO / Managing Director, Stockhausen Superabsorber GmbH

From 1 Oct 2026

Several senior leadership roles at INEOS Styrolution, driving growth and transformation

PhD in chemistry

Gregor Keil

Former CEO (first post-carve-out leader); now Chief Portfolio Officer, ICIG

Sep 2024 (presumed) – 30 Sep 2026

——

Jacqueline Skrzeba

Head of Communications

———

Michael Krzanowski

Head of Production Support (per third-party professional profile)

2023–present

Process engineer, INEOS Inovyn (2019–2023)

—

“—” = not publicly disclosed.

Board Committees

BodyMemberRoleSource

Supervisory Board, Stockhausen Superabsorber GmbH

Christoph Sprenger

Chairman

stockhausen.com Company Information

ICIG Supervisory Board

Dr. Achim Riemann

Chairman (ICIG group level)

AlChemPro, Sep 2024

Board & Management Changes

DateChangeContext

1 Sep 2024

Business moves to ICIG ownership; new management under the Stockhausen name

Carve-out from Evonik

1 Oct 2026

Dr. Eike Jahnke appointed CEO; Gregor Keil becomes ICIG Chief Portfolio Officer

Company credits Keil with strengthening the business in a challenging market; Jahnke hired for growth and transformation experience

Major Shareholders

HolderStakeSource

International Chemical Investors Group (ICI Holding SE)

100% (presumed; acquired the whole business unit)

Evonik/ICIG releases

Institutional holders

Not applicable (unlisted)

—

Competitive Landscape

Key Competitors

CompetitorHQListingRelative positioningSource for inclusion

Nippon Shokubai

Japan

Listed (Tokyo)

Global leader by capacity; integrated in acrylic acid; plants in Japan, US, Europe and Asia

Market reports (Barchart/MarketsandMarkets; RnR 2014)

BASF

Germany

Listed (Frankfurt)

Major hygiene SAP supplier with a global footprint

Multiple market reports

LG Chem

South Korea

Listed (Seoul)

Large Asian SAP producer; strong in eco-friendly SAP

GMI

Sumitomo Seika Chemicals

Japan

Listed (Tokyo)

Plants in Japan, France and Singapore

RnR 2014

SDP Global (Sanyo Chemical / Toyota Tsusho lineage)

Japan

Subsidiary

Long-established SAP supplier

Market reports

San-Dia Polymers / Sanyo Chemical Industries

Japan

Listed parent

Japanese SAP producer

GMI; market reports

Formosa Plastics

Taiwan

Listed

Integrated acrylics and SAP

Market reports

Yixing Danson Technology

China

Unlisted/regional

Named among top-6 capacity holders (2014)

RnR 2014

Wanhua Chemical

China

Listed (Shanghai)

Growing Chinese entrant

Future Market Insights (2026)

Zhejiang Satellite / Weilong / Quanzhou BLD

China

Various

Low-cost Chinese capacity

Market reports

Kao Corporation

Japan

Listed

SAP for in-house diaper brands

Market reports

Peer Comparison FY2023

MetricStockhausenNippon ShokubaiBASF (SAP)LG Chem (SAP)

SAP-related revenue

€892M (FY2023, includes merchant acrylic acid)

Not separately verified here

——

Growth

Declined in FY2023 (Europe)

———

Margins

About €20M average adjusted EBITDA (5-year); mid double-digit millions in FY2023

———

Acrylic acid integration

Yes (Marl)

Yes

Yes

Yes

Asian production

—

Yes

Yes

Yes

“—” = not publicly disclosed.

Recent Developments

To give useful context, the register starts in March 2024 with the transaction. Entries are marked by source reliability.

Items not found: * product launches with specifications, named contract wins, guidance revisions, litigation, regulatory penalties and quantified hiring.

Company Snapshot

$964.3M

Revenue

1,000

Employees

1873

Founded

Krefeld, Germany

Headquarters

SWOT Analysis

Strengths

  • Heritage technology leadership. Krefeld ran what the company describes as the world's first large-scale SAP plant (1986) [stockhausen.com].
  • Brand scale in hygiene. FAVOR® was in more than 40 billion diapers a year by 2011 [Evonik/CHEManager, 2011].
  • Backward integration into acrylic acid through the Marl plant, acquired in 1998 and still owned [stockhausen.com].
  • Application-technology depth. A dedicated €1M centre opened in Krefeld in 2015, and ICIG describes the business as a market leader in application technology [Evonik 2015; ICIG].
  • IP heritage. High-permeability SAP patents (US7169843B2, US7173086B2) and SAP fibre patents (EP1860215A2) [Google Patents; EPO].
  • ESG credentials. EcoVadis Silver (top 15%), ISCC PLUS certification, ISO 9001, 14001 and 50001 certificates, and Responsible Care [stockhausen.com].

Weaknesses

  • Thin historical profitability. Adjusted EBITDA averaged about €20M a year on sales of about €0.9B [Evonik, Mar 2024].
  • Low exit valuation. The low triple-digit million euro price implies a sharp discount to sales [Evonik, Mar 2024].
  • Geographic concentration. Production only in Germany and the US, with no Asian plants [stockhausen.com Sites].
  • European demand weakness. FY2023 sales fell on lower European demand [Specialty Chemicals Magazine].
  • Footprint uncertainty. The site list has dropped from five to four without explanation [stockhausen.com vs. ICIG].
  • Opacity. No published financials, which limits access to capital markets and investor confidence.

Opportunities

  • Commercialising bio-based SAP (FAVOR® Bio), where commercial scale is described as forthcoming [stockhausen.com Sustainability].
  • Adult incontinence growth with odour-control grades [stockhausen.com Products].
  • Specialty niches. CABLOC® for fibre and power cable roll-outs; STOCKOSORB® for water-scarce agriculture [stockhausen.com].
  • Mass-balance premium. Up to 100% ISCC PLUS allocation can win brand-owner scope-3 business [stockhausen.com].
  • ICIG synergies. Group procurement and shared services across a group with sales above €4B [ICIG].
  • New CEO's transformation experience from INEOS Styrolution [stockhausen.com, Oct 2026].

Threats

  • Asian capacity growth. Chinese producers such as Wanhua and Satellite are named among key players [Future Market Insights 2026; GMI].
  • Customer concentration and buying power. The industry structure favours a few global diaper makers.
  • Energy and feedstock volatility. Evonik's Performance Materials EBITDA swung from €409M (FY2022) to €111M (FY2023) [Evonik results].
  • Birth-rate decline in core markets.
  • Regulatory scrutiny of microplastics and polymers in the EU. This is an industry-wide risk; no company-specific disclosure exists.
  • Owner exit or restructuring risk. Typical for a carve-out under financial-investor ownership; the 2026 CEO change shows the business is still being transformed.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
4 Mar 2024Evonik signs sale of superabsorbents to ICIG; FY2023 sales €892M; low triple-digit million euro price Evonik release (high)Sets the carve-out valuation and confirms thin historical margins
4 Mar 2024Evonik CEO Christian Kullmann says the business no longer fits Evonik's specialty-chemicals profile Evonik release (high)Shows Evonik saw the business as non-core and commodity-like
4 Mar 2024Evonik discloses about €20M average adjusted EBITDA over five years Evonik release (high)Key profitability benchmark
31 Aug 2024Deal closes after antitrust clearance Evonik/ICIG (high)Start of independence
1 Sep 2024Business joins ICIG; Stockhausen name revived stockhausen.com (high)Brand reset
Sep 2024ICIG supervisory board chair Dr. Achim Riemann welcomes superabsorbents as a new platform AlChemPro (high)Owner commitment
Sep 2024ICIG group reports sales well above €4B, about 50 sites and 7,800+ employees after the deal Medical Device Developments (medium-high)Owner scale
Oct 2024Stockhausen Superabsorber GmbH registered in Germany; legal notice issued under the new name stockhausen.com (high)Legal separation complete
4 Dec 2024Named "Family-friendly Company 2024/2025" in Krefeld stockhausen.com (high)Employer brand
2025 (undated)US entity operating as Stockhausen Superabsorber LLC; US terms and conditions published stockhausen.com Documents (high)US legal rebrand complete
2025 (undated)EcoVadis Silver rating, top 15% globally stockhausen.com (high)ESG credential for customer qualification
2025 (undated)Code of Conduct, Supplier Code and whistleblower system published under the Stockhausen brand stockhausen.com (high)Governance build-out
23 Sep 2025Legal notice page last updated stockhausen.com metadata (high)Administrative
Early Feb 2026Third-party WARN Act aggregator lists a Louisiana WARN notice for "Stockhausen Superabsorber". The reported worker count (3,606) matches the Garyville street number (3606 LA-44) and the listed cities are inconsistent (Geismar / Baton Rouge), so the data is plainly garbled warnfirehose.com (low)Possible Garyville workforce action. Unconfirmed; the count is not credible, as the 2017 site headcount was about 120
6 Mar 2026News page updated with a "Fairness & Inclusion" statement stockhausen.com (high)DEI policy
Apr 2026Sites page updated; now lists four sites (Krefeld, Rheinmünster, Marl, Greensboro) and omits Garyville stockhausen.com Sites (high for the listing; inference for the exit)Strong signal of a Garyville exit or reclassification. Not explicitly announced
27–30 Apr 2026Homepage, About Us and Products pages refreshed; FAVOR® Bio described as in a focused market phase with selected partners stockhausen.com (high)Commercialisation of bio-SAP under way but not yet at scale
21 Aug 2026Sustainability page updated: ISCC PLUS, EcoVadis Silver, Responsible Care; FAVOR® Bio at commercial scale described as forthcoming stockhausen.com (high)Sustainability positioning
1 Oct 2026Dr. Eike Jahnke (ex-INEOS Styrolution) appointed CEO stockhausen.com (high)New leadership for the next phase of transformation
1 Oct 2026Gregor Keil moves to ICIG as Chief Portfolio Officer stockhausen.com (high)Continuity; former CEO stays connected through the owner
1 Oct 2026Company Information page updated with Jahnke as sole managing director and Christoph Sprenger as supervisory board chair stockhausen.com (high)Governance confirmation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Segment (FY2023): Total business sales was EUR 892 Mn in FY2023.
Stockhausen Inc. — Revenue by Segment (FY2023)
Series (EUR Mn)FY2023
Total business sales892

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Stockhausen Superabsorber: homepage, About Us, Products, Sustainability, News, Sites, Contact & Documents/Company Information, Legal Notice. (accessed 7 Oct 2026) (stockhausen.com)
  2. Stockhausen news, "Dr. Eike Jahnke appointed as new CEO at Stockhausen" (1 Oct 2026). (stockhausen.com)
  3. Evonik press release, "Evonik sells superabsorbents business to ICIG – second step in divestment of Performance Materials" (4 Mar 2024). (evonik.com)
  4. ICIG news, "Evonik and ICIG complete sale of superabsorbents business" (Sep 2024). (ic-investors.com)
  5. ICIG: Stockhausen platform page and site pages for Greensboro and Garyville. (ic-investors.com)
  6. SpecialChem, "Evonik Completes Sale of Its Superabsorbents Business Unit to ICIG" (6 Sep 2024)
  7. CHEManager, "Evonik und ICIG schließen Verkauf des Superabsorber-Geschäfts ab" (2 Sep 2024)
  8. AlChemPro, "Germany's Evonik finalises sale of Superabsorbents unit to ICIG" (4 Sep 2024)
  9. Medical Device Developments, coverage of the Evonik/ICIG closing (Sep 2024)
  10. Coatings World, "Evonik to sell superabsorbents business to ICIG" (2024)
  11. Polymers Paint Colour Journal, coverage of the Evonik/ICIG deal (2024)
  12. Specialty Chemicals Magazine, "Evonik to change structure, sell superabsorbents" (2024)
  13. PCI Magazine, "Evonik reports 2022 financial results"
  14. Evonik Q2 2021 results release; Evonik Q1 2022 key figures
  15. Indian Chemical News, "Evonik Q1 FY23 adjusted EBITDA down 44%" (May 2023)
  16. FDA, Environmental Assessment for FAVOR® PAC 100, Stockhausen, Inc. (3 Feb 1997). (fda.gov)
  17. Google Patents: US7169843B2 and US7173086B2 (assignment histories)
  18. European Patent Office: EP1860215A2
  19. CHEManager / Evonik, "25 Jahre Superabsorberproduktion in Krefeld" (Dec 2011)
  20. Evonik press release, new SAP application technology centre, Krefeld (27 Apr 2015)
  21. CHEManager, "Evonik reduziert Produktionskapazität für Superabsorber" (12 Sep 2016)
  22. L'Observateur, "THE SUPERABSORBERS: Evonik Garyville celebrates 30 years" (24 May 2017)
  23. Nonwovens Industry, Degussa Superabsorber appointment (Nov 2005)
  24. WARN Firehose, Louisiana WARN aggregator pages (2026). Low reliability; data appears garbled
  25. Global Market Insights, Superabsorbent Polymer Market

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.